SOLVE-TAVI after 12-month followup: self-expanding vs. balloon expandable and general vs. local anesthesia

The ambitious SOLVE-TAVI (soon to be published in JACC) is aimed at answering to of the most important questions we make when facing a TAVR procedure: What valve do we choose, a self-expanding or a balloon expandable? And once we have chosen our device, do we proceed with general anesthesia or conscious sedation? 

Sedación consciente vs anestesia general en el TAVI

 

The SOLVE-TAVI had already shown no major differences at 30 days between devices or sedation strategies. At present, after one year, we look forward to these results. 

Using a 2 × 2 factorial design, 447 intermediate to high-risk patients with severe, symptomatic aortic stenosis were randomly assigned to transfemoral TAVR using the self-expanding Evolut R vs. the balloon expandable Sapien 3.  Following the 2 x 2 design, patients were randomized to general anesthesia vs. conscious sedation at the same time. 

When comparing devices, the combined end point rate (all-cause mortality, stroke, moderate to severe paravalvular leak and need of permanent pacemaker implantation) resulted similar between prosthesis at one year (38.3% vs 40.4%, HR 0.94, CI 95% 0.7 to 1.26; p=0.66).

As regards sedation, outcomes were as disappointing: general anesthesia resulted similar to conscious sedation when it came to the combined end point of all-cause mortality, stroke, MI and acute kidney injury (25.7% vs 23.8%, HR 1.09, CI 95% 0.76 to 1.57; p=0.63).


Read also: TCT 2018 | SOLVE-TAVI: Self-Expandable vs. Balloon-Expandable Valves and General vs. Local Anesthesia in One Study.


Probablemente, para la enorme mayoría de los pacientes la elección de la válvula o el tipo de anestesia todavía pase por la experiencia de cada operador y equipo. Sin embargo, existen diferencias sutiles de subgrupos que pueden inclinar la balanza hacia una u otra válvula como también al tipo de anestesia.

Conclusión

En pacientes de riesgo intermedio o alto que reciben TAVI transfemoral no se observaron diferencias al año entre las actuales generaciones de la válvula autoexpandible y la válvula balón expandible. Los tipos de anestesia tampoco mostraron diferencias significativas en el mismo período de tiempo.

Título original: Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement.

Referencia: Hans-Josef Feistritzer et al. J Am Coll Cardiol. 2021 May, 77 (17) 2204–2215.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...